RJA
SNY icon

Raymond James & Associates’s Sanofi SNY Stock Holding History

Raymond James & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$162M Buy
2,819,348
+129,472
+5% +$6.99M 0.1% 178
2024
Q2 		$131M Buy
2,689,876
+374,621
+16% +$18.1M 0.09% 201
2024
Q1 		$113M Buy
2,315,255
+491,498
+27% +$24M 0.08% 230
2023
Q4 		$90.7M Sell
1,823,757
-272,385
-13% -$13.3M 0.07% 247
2023
Q3 		$112M Buy
2,096,142
+31,773
+2% +$1.69M 0.09% 189
2023
Q2 		$111M Buy
2,064,369
+308,353
+18% +$16.6M 0.09% 193
2023
Q1 		$95.6M Buy
1,756,016
+800,615
+84% +$38.9M 0.08% 215
2022
Q4 		$46.3M Buy
955,401
+156,392
+20% +$6.86M 0.04% 368
2022
Q3 		$30.4M Sell
799,009
-155,147
-16% -$6.91M 0.03% 448
2022
Q2 		$47.7M Buy
954,156
+56,898
+6% +$3.02M 0.05% 332
2022
Q1 		$46.1M Buy
897,258
+53,822
+6% +$2.78M 0.04% 383
2021
Q4 		$42.3M Buy
843,436
+63,487
+8% +$3.14M 0.03% 435
2021
Q3 		$37.6M Buy
779,949
+48,361
+7% +$2.46M 0.03% 441
2021
Q2 		$38.5M Buy
731,588
+48,407
+7% +$2.53M 0.04% 432
2021
Q1 		$33.8M Sell
683,181
-59,564
-8% -$2.86M 0.03% 442
2020
Q4 		$36.1M Sell
742,745
-222,152
-23% -$11M 0.04% 397
2020
Q3 		$48.4M Sell
964,897
-48,281
-5% -$2.49M 0.06% 266
2020
Q2 		$51.7M Sell
1,013,178
-91,600
-8% -$4.45M 0.07% 239
2020
Q1 		$48.3M Buy
1,104,778
+48,415
+5% +$2.32M 0.08% 222
2019
Q4 		$53M Buy
1,056,363
+63,919
+6% +$2.99M 0.07% 254
2019
Q3 		$46M Sell
992,444
-11,065
-1% -$477K 0.06% 268
2019
Q2 		$43.4M Buy
1,003,509
+135,604
+16% +$5.77M 0.06% 296
2019
Q1 		$38.4M Buy
867,905
+93,159
+12% +$3.99M 0.06% 313
2018
Q4 		$33.6M Buy
774,746
+83,399
+12% +$3.68M 0.06% 301
2018
Q3 		$30.9M Sell
691,347
-938,951
-58% -$40.1M 0.05% 374
2018
Q2 		$65.2M Sell
1,630,298
-47,354
-3% -$1.86M 0.11% 177
2018
Q1 		$67.2M Sell
1,677,652
-117,124
-7% -$4.87M 0.12% 165
2017
Q4 		$77.2M Sell
1,794,776
-551,981
-24% -$25.5M 0.14% 133
2017
Q3 		$117M Sell
2,346,757
-489,150
-17% -$23.7M 0.23% 87
2017
Q2 		$136M Sell
2,835,907
-318,540
-10% -$15.2M 0.29% 63
2017
Q1 		$143M Buy
3,154,447
+276,323
+10% +$11.7M 0.33% 52
2016
Q4 		$116M Sell
2,878,124
-363,887
-11% -$14.3M 0.3% 57
2016
Q3 		$124M Buy
3,242,011
+1,235,063
+62% +$49.6M 0.34% 53
2016
Q2 		$84M Buy
2,006,948
+753,535
+60% +$30.9M 0.26% 73
2016
Q1 		$50.3M Buy
1,253,413
+378,815
+43% +$15.2M 0.17% 126
2015
Q4 		$37.3M Sell
874,598
-5,405
-0.6% -$249K 0.13% 162
2015
Q3 		$41.8M Buy
880,003
+13,957
+2% +$711K 0.17% 131
2015
Q2 		$42.9M Buy
866,046
+59,700
+7% +$3.03M 0.16% 125
2015
Q1 		$39.9M Buy
806,346
+403,121
+100% +$19.3M 0.18% 113
2014
Q4 		$18.4M Buy
403,225
+23,717
+6% +$1.15M 0.09% 245
2014
Q3 		$21.4M Buy
379,508
+20,405
+6% +$1.1M 0.12% 172
2014
Q2 		$19.1M Sell
359,103
-41,021
-10% -$2.18M 0.12% 189
2014
Q1 		$20.9M Buy
400,124
+36,627
+10% +$1.85M 0.14% 150
2013
Q4 		$19.5M Buy
363,497
+47,908
+15% +$2.47M 0.15% 148
2013
Q3 		$16M Buy
315,589
+14,753
+5% +$751K 0.14% 151
2013
Q2 		$15.5M Buy
+300,836
New +$16M 0.15% 140

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James & Associates's SNY Position: Q3 2024 in Review

Raymond James & Associates increased its Sanofi (SNY) stake by 4.8% in Q3 2024, buying an estimated $6.99M and bringing the position to 2,819,348 shares worth $162M. The position accounts for 0.1% of the portfolio, ranked #178.

Raymond James & Associates first reported a position in SNY in Q2 2013 and has held it in 46 quarters since. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Raymond James & Associates held 2,819,348 shares of Sanofi worth $162M as of Q3 2024.
  • Raymond James & Associates bought 129,472 Sanofi shares in Q3 2024, an estimated $6.99M.
  • Sanofi made up 0.1% of Raymond James & Associates's portfolio in Q3 2024, its #178 holding.
  • Raymond James & Associates first reported a position in Sanofi in Q2 2013 and has held it in 46 quarters since.
  • 756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.